Relapse rates in an early psychosis treatment service

被引:23
作者
Addington, D.
Addington, M. D. Jean
Patten, S.
机构
[1] Univ Calgary, Dept Psychiat, Calgary, AB T2N 1N4, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON M4X 1K9, Canada
[3] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada
关键词
schizophrenia; schizoaffective disorder; early psychosis treatment services; treatment outcome; relapse; FIRST-EPISODE SCHIZOPHRENIA; EARLY INTERVENTION; FOLLOW-UP; UNTREATED PSYCHOSIS; NATURAL COURSE; 1ST EPISODE; PREDICTORS; HALOPERIDOL; RISPERIDONE; DISORDERS;
D O I
10.1111/j.1600-0447.2006.00879.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: To examine the relapse rate achievable in a real-life early psychosis treatment service. Method: A 2-year longitudinal cohort study of consecutive admissions to an early psychosis programme which served the entire population in a catchment area. The primary outcome measure was relapse. Results: One hundred and forty-eight consecutive consenting admissions were recruited, 124 (83.8%) of whom were followed for 1 year and 116 (78.4%) for 2 years. Relapse was assessed by clinicians using structured criteria. The 2-year relapse rate among subjects with complete data collection was 34/95 (35.7%, 95% CI 26.2-46.3). A Kaplan-Meier life table censoring subjects lost to follow-up yielded a comparable estimate of the proportion not relapsing: 68% (95% CI 58-76%). Conclusion: These estimates compare favourably with a published range of 2-year relapse from 55% to 70% in the older literature and are comparable with the results in recent clinical trials.
引用
收藏
页码:126 / 131
页数:6
相关论文
共 36 条
  • [1] Performance measures for early psychosis treatment services
    Addington, D
    McKenzie, E
    Addington, J
    Patten, S
    Smith, H
    Adair, C
    [J]. PSYCHIATRIC SERVICES, 2005, 56 (12) : 1570 - 1582
  • [2] The role of family work in early psychosis
    Addington, J
    Collins, A
    McCleery, A
    Addington, D
    [J]. SCHIZOPHRENIA RESEARCH, 2005, 79 (01) : 77 - 83
  • [3] Addington J., 2001, Canadian Psychiatric Association Bulletin, V33, P11
  • [4] *AG HEALTHC RES QU, 2005, SYST RAT STRENGTH SC, V47, P1
  • [5] Relapse in schizophrenia: costs, clinical outcomes and quality of life
    Almond, S
    Knapp, M
    Francois, C
    Toumi, M
    Brugha, T
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2004, 184 : 346 - 351
  • [6] [Anonymous], 2004, British Medical Journal, DOI DOI 10.1136/bmj.329.7456.1
  • [7] Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of 1-year studies
    Correll, CU
    Leucht, S
    Kane, JM
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (03) : 414 - 425
  • [8] Pattern of health service utilization and predictors of readmission after a first admission for psychosis: a 2-year follow-up study
    Cougnard, A
    Parrot, M
    Grolleau, S
    Kalmi, E
    Desage, A
    Misdrahi, D
    Brun-Rousseau, H
    Verdoux, H
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2006, 113 (04) : 340 - 349
  • [9] Is there an association between duration of untreated psychosis and 24-month clinical outcome in a first-admission series?
    Craig, TJ
    Bromet, EJ
    Fennig, S
    Tanenberg-Karant, M
    Lavelle, J
    Galambos, N
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (01) : 60 - 66
  • [10] A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia
    Csernansky, JG
    Mahmoud, R
    Brenner, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (01) : 16 - 22